SLC26A2 and chondrodysplasia: Another study in mice found a novel therapeutic target in the lethal forms of SLC26A2-related chondrodysplasias by discovering overactive fibroblast growth factor 3 (Fgfr3) signaling in slc26a2−/− mice.